The PROLONG Trial - Rituximab Maintenance Therapy in ITP

NCT03010202 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Purpura, Thrombocytopenic, Idiopathic

Interventions

DRUG: Dexamethasone
DRUG: Rituximab

Sponsor

Ostfold Hospital Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]